跳至主要内容
临床试验/JPRN-UMIN000037575
JPRN-UMIN000037575招募中未知

Efficacy and safety of interferon-free treatment in patients with chronic hepatitis C - Efficacy and safety of interferon-free treatment in patients with chronic hepatitis C

Osaka university0 个研究点目标入组 1,000 人开始时间: 2019年8月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients treated with contraindicated drug together with direct acting antivirals 2. Patients who were judged inadequate to participate by researchers.

研究者

相似试验

招募中
不适用
Analysis of efficacy and safety of interferon-free therapy for recurrent hepatitis C after liver transplantatiohepatitis C after liver transplantation
JPRN-UMIN000018759Kyoto University Hospital50
招募中
不适用
ong-term effect of interferon-free treatment in subjects with hepatitis C virus (HCV)-related decompensated cirhosisdecompensated cirrhosis
JPRN-UMIN000034735Osaka University102
进行中(未招募)
1 期
The purpose of this study is to evaluate how effective, safe and tolerable Sofosbuvir (SOF)/Velpatasvir(VEL) is when taken by people with recent hepatitis C virus (HCV) infection, in particular whether the length of treatment can be shortened. Study participants will be randomly (occur by chance) assigned into one of the two different groups. The short treatment duration group will receive SOF/VEL for 6 weeks and the standard treatment duration group will receive SOF/VEL for 12 weeks.Recent hepatitis C virus infection all genotypes.MedDRA version: 20.0Level: PTClassification code 10019744Term: Hepatitis CSystem Organ Class: 10021881 - Infections and infestations
EUCTR2015-004243-39-NLniversity of New South Wales Australia250
进行中(未招募)
1 期
A study to evaluate how effective, safe and tolerable Sofosbuvir/Velpatasvir is when taken by people with recent hepatitis C virus infection, in particular whether the length of treatment can be shortened.Recent hepatitis C virus infection all genotypes.MedDRA version: 20.0Level: PTClassification code 10019744Term: Hepatitis CSystem Organ Class: 10021881 - Infections and infestations
EUCTR2015-004243-39-GBThe University of New South Wales Australia250
招募中
不适用
Efficacy of interferon therapy for recurrence-free and overall survival after curative radiofrequency ablation for HCV-related hepatocellular carcinoma.hepatocellular carcinoma
JPRN-UMIN000006761Kyoundo hospital50